[1]
Devajit Mohajan and Haradhan Kumar Mohajan, “Glucagon-Like Peptide-1 Receptor Agonist (GLP-1R): An Important Therapy to Treat Type 2 Diabetes”, JIMR, vol. 3, no. 3, pp. 1–6, Aug. 2024.